Novel candidate tumour suppressor gene loci on chromosomes 11q23-24 and 22q13 involved in human isulinoma tumourigenesis

Journal of Pathology

Volumn 210, Issue 4, 2006, Pages 450-458

  Jonkers, Y M H ^a   Claessen, S M H ^a   Feuth, T ^b   van Kessel, A Geurts ^b   Ramaekers, F C S ^a   Veltman, J A ^b   Speel, E J M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

9q; Array comparative genomic hybridization; Chromosome; Endocrine pancreatic tumours; Fluorescence in situ hybridization; Insulinoma

Indexed keywords

CYSTEINE; GLYCINE; HISTIDINE;

ADULT; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CARCINOGENESIS; CHROMOSOME 11Q; CHROMOSOME 22Q; CHROMOSOME 9Q; CHROMOSOME ABERRATION; CHROMOSOME ADDITION; CHROMOSOME LOSS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA HYBRIDIZATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE IDENTIFICATION; GENE LOCUS; GENE STRUCTURE; HUMAN; HUMAN TISSUE; INSULINOMA; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; TUMOR CELL; TUMOR SUPPRESSOR GENE; VALIDATION PROCESS;

CHROMOSOMAL INSTABILITY; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 22; CHROMOSOMES, HUMAN, PAIR 4; CHROMOSOMES, HUMAN, PAIR 9; DNA, NEOPLASM; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INSULINOMA; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PLOIDIES;

EID: 33751504040     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2072     Document Type: Article

References (31)

1. Komminoth P, Perren A, Öberg K, Rindi G, Heitz PU, Klöppel G. Insulinoma. In Pathology & Genetics. Tumours of Endocrine Organs, DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds). IARC Press: Lyon, 2004; 183-186.
2. Jonkers YMH, Claessen SMH, Perren A, Schmid S, Komminoth P, Verhofstad AA, et al. Chromosomal instability predicts metastatic disease in patients with insulinomas. Endocr Relat Cancer 2005;12:435-447.
3. Bartsch DK, Kersting M, Wild A, Ramaswamy A, Gerdes B, Schuermann M, et al. Low frequency of p16 (INK4a) alterations in insulinomas. Digestion 2000;62:171-177.
4. Moore PS, Missiaglia E, Antonello D, Zamo A, Zamboni G, Corleto V, et al. Role of disease-causing genes in sporadic pancreatic endocrine tumours: MEN1 and VHL. Genes Chromosomes Cancer 2001;32:177-181.
5. Solinas-Toldo S, Lampel S, Stilgenbauer S, Nickolenko J, Benner A, Döhner H, et al. Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer 1997;20:399-407.
6. Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D, et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nature Genet 1998;20:207-211.
7. Richter J, Jiang F, Görög JP, Sartorius G, Egenter C, Gasser TC, et al. Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization. Cancer Res 1997;57:2860-2864.
8. Wessendorf S, Fritz B, Wrobel G, Nessling M, Lampel S, Göettel D, et al. Automated screening for genomic imbalances using matrix-based comparative genomic hybridization. Lab Invest 2002;82:47-60.
9. Veltman JA, Jonkers YMH, Nuijten I, Janssen I, van der Vliet W, Huys E, et al. Definition of a critical region on chromosome 18 for congenital aural atresia by array CGH. Am J Hum Genet 2003;72:1578-1584.
10. Davies JJ, Wilson IM, Lam WL. Array CGH technologies and their applications to cancer genomes. Chromosome Res 2005;13:237-248.
11. Pinkel D, Albertson DG. Array comparative genomic hybridization and its applications in cancer. Nature Genet 2005;37:11-17.
12. Veltman JA, Schoenmakers EF, Eussen BH, Janssen I, Merkx G, van Cleef B, et al. High-throughput analysis of subtelomeric chromosome rearrangements by use of array-based comparative genomic hybridization. Am J Hum Genet 2002;70:1269-1276.
13. Zafarana G, Grygalewicz B, Gillis AJ, Vissers LE, van de Vliet W, van Gurp RJ, et al. 12p-amplicon structure analysis in testicular germ cell tumors of adolescents and adults by array CGH. Oncogene 2003;22:7695-7701.
14. Vissers LELM, de Vries BBA, Osoegawa K, Janssen IM, Feuth T, Choy CO. Array-based comparative genomic hybridization for the genome wide detection of submicroscopic chromosomal abnormalities. Am J Hum Genet 2003;73:1261-1270.
15. Fridlyand J, Snijders AM, Pinkel D, Albertson DG, Jain AN. Hidden Markov models approach to the analysis of array CGH data. J Multivar Anal 2004;90:132-153.
16. Speel EJM, Scheidweiler AF, Zhao J, Matter C, Saremaslani P, Roth J, et al. Genetic evidence for early divergence of small functioning and nonfunctioning endocrine pancreatic tumors: gain of 9q34 is an early event in insulinomas. Cancer Res 2001;61:5186-5192.
17. Debelenko LV, Zhuang Z, Emmert-Buck MR, Chandrasekharappa SC, Manickam P, Guru SC, et al. Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors. Cancer Res 1997;57:2238-2243.
18. Chakrabarti R, Srivatsan ES, Wood TF, Eubanks PJ, Ebrahimi SA, Gatti RA, et al. Deletion mapping of endocrine tumors localizes a second tumor suppressor gene on chromosome band 11q13. Genes Chromosomes Cancer 1998;22:130-137.
19. Görtz B, Roth J, Krähenmann A, de Krijger RR, Muletta-Feurer S, Rutimann K, et al. Mutations and allelic deletions of the MEN 1 gene are associated with a subset of sporadic endocrine pancreatic and neuroendocrine tumors and not restricted to foregut neoplasms. Am J Pathol 1999;154:429-436.
20. Hessman O, Lindberg D, Einarsson A, Lillhager P, Carling T, Grimelius L, et al. Genetic alterations on 3p, 11q13, and 18q in nonfamilial and MEN 1-associated pancreatic endocrine tumors. Genes Chromosomes Cancer 1999;26:258-264.
21. Chandrasekharappa. SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 1997;276:404-407.
22. Broustas CG, Gokhale PC, Rahman A, Dritschilo A, Ahmad I, Kasid U. BRCC2, a novel BH3-like domain-containing protein, induces apoptosis in a caspase-dependent manner. J Biol Chem 2004;279:26780-26788.
23. Pelengaris S, Khan M, Evan GI. Suppression of Myc-induced apoptosis in β cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression. Cell 2002;109:321-334.
24. Kops GJPL, Kim Y, Weaver BAA, Mao Y, McLeod I, Yates JR, et al. ZW10 links mitotic checkpoint signaling to the structural kinetochore. J Cell Biol 2005;169:49-60.
25. Perren A, Barghorn A, Schmid S, Saremaslani P, Roth J, Heitz PU, et al. Absence of somatic SDHD mutations in sporadic neuroendocrine tumors and detection of two germline variants in paraganglioma patients. Oncogene 2002;21:7605-7608.
26. Gutmann DH. The neurofibromatosis: when less is more. Hum Mol Genet 2001;10:747-755.
27. Wild A, Langer P, Ramaswamy A, Chaloupka B, Bartsch DK. A novel insulinoma tumor suppressor gene locus on chromosome 22q with potential prognostic implications. J Clin Endocrinol Metab 2001;86:5782-5787.
28. Johnstone CN, Castellvi-Bel S, Chang LM, Sung RK, Bowser MJ, Pique JM, et al. PRR5 encodes a conserved praline-rich protein predominant in kidney: analysis of genomic organization, expression, and mutation status in breast and colorectal carcinomas. Genomics 2005;85:338-351.
29. Castellvi-Bel S, Castells A, Johnstone CN, Pinol V, Pelisse M, Elizalde JI, et al. Evaluation of PARVG located on 22q13 as a candidate tumor suppressor gene for colorectal and breast cancer. Cancer Genet Cytogenet 2003;144:80-82.
30. Terui E, Matsunaga T, Yoshida H, Kouchi K, Kuroda H, Hishiki T, et al. She family expression in neuroblastoma: high expression of shcC is associated with a poor prognosis in advanced neuroblastoma. Clin Cancer Res 2005;11:3280-3287.
31. Jonkers YMH, Claessen SMH, Veltman JA, Geurts van Kessel A, Dinjens WNM, Skogseid B, et al. Molecular parameters associated with insulinoma progression: chromosomal instability versus p53 and CK19 status. Cytogenet Genome Res 2006;115:289-297.